In the United States, approximately 8 to 12 million people are affected with peripheral artery disease (PAD), a form of atherosclerotic disease. PAD can reduce blood flow in the lower limbs, resulting in pain, loss of motility, foot ulcers and the potential for loss of limb. This end result, termed critical limb ischemia (CLI), is treated surgiclly or endoscopically in an effort to enhance blood flow to the limb. Of patients affected by CLI, 20-30% are not suitable for revascularization procedures and may have to be amputated. This has prompted clinical investigation into both medical therapies to achieve therapeutic revascularization as well as cellular therapies. We have described for the first time that an insoluble matrix can control cellular differentiation of mesenchymal stem cells (MSCs) towards vascular cells without additional soluble signals. Our preliminary studies show that MSCs cultured in a hydrogel matrix express genotypic, phenotypic and morphologic characteristics of endothelial cells and pericytes in the absence of additional cytokines. In vivo results indicate that these phenotypic changes lead to increased neovascularization, which may be an enabling step for the functional improvement of a regenerable tissue like skeletal muscle. Therefore, we are interested in understanding the process of vasculogenesis from progenitor cells for the purpose of enabling muscle regeneration. Central to our understanding of this process is the necessity of being able to track stem cells and the resulting newly formed vasculature. An essential requirement for stem cell labels is that they are not toxic over time. It is also essentil that imaging must not alter the behavior or fate of marked stem cell populations. We propose here to utilize spherical gold nanoparticles, plasmonic nantracers, due to their excellent biocompatibility, as well as high and tunable optical absorption properties. Several approaches are available to either track stem cells or to measure neovascularization, but none of the approaches can monitor both simultaneously. Therefore, the overall goal of the current proposal is to quantify blood vessel growth kinetics and function in vivo using nanotracer-enhanced, high-resolution combined ultrasound and photoacoustic (US/PA) imaging. A secondary goal is to be able to quantify revascularization in a model system in which we are able to correlate the extent and structure of blood vessels with quantitative measures of muscle function. The combination of nanotracers with US/PA imaging results in a unique single system approach capable of quantifying blood vessel development from progenitor cells. This will allow us to answer fundamental questions regarding MSC involvement in blood vessel growth as well as validate a clinically translatable solution for tissue regeneration.

Public Health Relevance

Early clinical trials in patients with peripheral arterial disease resulting in critical limb ischemia have demonstrated the safety of autologous stem cell therapies and suggested modest improvements in reperfusion and limb salvage. A major challenge to the development of clinically applied stem cell therapy remains the lack of efficient stem cell tracking methods and in vivo visualization of neovascularization. Therefore, the overall goal of the current proposal is to quantify blood vessel growth kinetics and function in vivo using nanotracer-enhanced, high-resolution combined ultrasound and photoacoustic (US/PA) imaging.

National Institute of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Research Project (R01)
Project #
Application #
Study Section
Nanotechnology Study Section (NANO)
Program Officer
Hunziker, Rosemarie
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Austin
Biomedical Engineering
Biomed Engr/Col Engr/Engr Sta
United States
Zip Code
Rybalko, Viktoriya; Hsieh, Pei-Ling; Ricles, Laura M et al. (2017) Therapeutic potential of adipose-derived stem cells and macrophages for ischemic skeletal muscle repair. Regen Med 12:153-167
Santiesteban, Daniela Y; Kubelick, Kelsey; Dhada, Kabir S et al. (2016) Monitoring/Imaging and Regenerative Agents for Enhancing Tissue Engineering Characterization and Therapies. Ann Biomed Eng 44:750-72
Ricles, Laura M; Hsieh, Pei-Ling; Dana, Nicholas et al. (2016) Therapeutic assessment of mesenchymal stem cells delivered within a PEGylated fibrin gel following an ischemic injury. Biomaterials 102:9-19
Rybalko, Viktoriya Y; Pham, Chantal B; Hsieh, Pei-Ling et al. (2015) Controlled delivery of SDF-1? and IGF-1: CXCR4(+) cell recruitment and functional skeletal muscle recovery. Biomater Sci 3:1475-86
Hammers, David W; Rybalko, Viktoriya; Merscham-Banda, Melissa et al. (2015) Anti-inflammatory macrophages improve skeletal muscle recovery from ischemia-reperfusion. J Appl Physiol (1985) 118:1067-74
Chung, Eunna; Rytlewski, Julie A; Merchant, Arjun G et al. (2015) Fibrin-based 3D matrices induce angiogenic behavior of adipose-derived stem cells. Acta Biomater 17:78-88
Nam, Seung Yun; Chung, Eunna; Suggs, Laura J et al. (2015) Combined ultrasound and photoacoustic imaging to noninvasively assess burn injury and selectively monitor a regenerative tissue-engineered construct. Tissue Eng Part C Methods 21:557-66
Rytlewski, Julie A; Alejandra Aldon, M; Lewis, Evan W et al. (2015) Mechanisms of tubulogenesis and endothelial phenotype expression by MSCs. Microvasc Res 99:26-35
Tu, Chengyi; Das, Subhamoy; Baker, Aaron B et al. (2015) Nanoscale strategies: treatment for peripheral vascular disease and critical limb ischemia. ACS Nano 9:3436-52
Rybalko, Viktoriya; Hsieh, Pei-Ling; Merscham-Banda, Melissa et al. (2015) The Development of Macrophage-Mediated Cell Therapy to Improve Skeletal Muscle Function after Injury. PLoS One 10:e0145550

Showing the most recent 10 out of 20 publications